{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:20:19Z","timestamp":1791069619604,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007780","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T00:00:00Z","timestamp":1295395200000}}],"reference-count":69,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007780.pub2","type":"journal-article","created":{"date-parts":[[2011,1,6]],"date-time":"2011-01-06T00:53:10Z","timestamp":1294275190000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cisapride for Intestinal Constipation"],"prefix":"10.1002","author":[{"given":"Omar M","family":"Aboumarzouk","sequence":"first","affiliation":[{"name":"Cym Taf NHS Trust; Urology Department; Merthyr Tydfil Wales UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Northern General Hospital, Sheffield; 15 Centurion Way Wooton Fields Northhampton UK NN4 6LD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramez","family":"Antakia","sequence":"additional","affiliation":[{"name":"Sheffield Teaching Hospitals NHS Foundation Trust; General & Colorectal Surgery, Doctors Accomodation, Block A; Doncaster Royal Infirmary, Armthorpe Road South Yorkshire UK DN2 5LT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Shariff","sequence":"additional","affiliation":[{"name":"Sheffield Teaching Hospitals NHS Foundation Trust; General and Colorectal Surgery; Northern General Hospital Herries Road Sheffield UK S5 7AU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L","family":"Nelson","sequence":"additional","affiliation":[{"name":"Northern General Hospital; Department of General Surgery; Herries Road Sheffield Yorkshire UK S5 7AU"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,19]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD007780.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/00365529850166833","article-title":"The symptomatic effect of cisapride in patients with irritable bowel syndrome and constipation.","volume":"33","author":"Farup","year":"1998","journal-title":"Scand J Gastroenterol."},{"issue":"2","key":"10.1002\/14651858.CD007780.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00005176-199902000-00020","article-title":"Cisapride in management of chronic pediatric constipation.","volume":"28","author":"Halabi","year":"1999","journal-title":"\u00a0J Pediatr Gastroenterol Nutr."},{"issue":"1","key":"10.1002\/14651858.CD007780.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-3476(00)90046-5","article-title":"Cisapride for the treatment of constipation in children: A double-blind study","volume":"136","author":"Nurko","year":"2000","journal-title":"J Pediatr."},{"issue":"2","key":"10.1002\/14651858.CD007780.pub2-BIB0004|cit4","first-page":"250","article-title":"Use of cisapride in treatment of idiopathic constipation in children.","volume":"25","author":"Odeka","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr."},{"issue":"6","key":"10.1002\/14651858.CD007780.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF01311229","article-title":"Effect of Cisapride on Chronic Idiopathic Consipation in Children","volume":"36","author":"Staiano","year":"1991","journal-title":"Digestive Diseases and Sciences"},{"issue":"1","key":"10.1002\/14651858.CD007780.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004836-199102000-00012","article-title":"\"Prokinetic\" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride.","volume":"13","author":"Outryve","year":"1991","journal-title":"J Clin Gasroenterol"},{"issue":"6","key":"10.1002\/14651858.CD007780.pub2-BIB0007|cit7","first-page":"978","article-title":"Double-blind comparison of two cisapride dosage regimens with placebo in the treatment of functional constipation. A general-practice multicenter study","volume":"41","author":"Verheyen","year":"1987","journal-title":"Current Therapeutic Research - Clinical and Experimental"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1400-1746.2004.03384.x","article-title":"Cisapride treatment of constipation-predominant irritable bowel syndrome is not superior to placebo","volume":"19","author":"Ziegenhagen","year":"2004","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD007780.pub2-BIB0009|cit9","first-page":"197","article-title":"The Efficacy of Cisapride vs. Placebo and Diet in patients with Chronic Consitpation","volume":"27","author":"Altabas","year":"2003","journal-title":"Coll Antopol"},{"issue":"Suppl. 5","key":"10.1002\/14651858.CD007780.pub2-BIB0010|cit10","first-page":"A575","article-title":"Cisapride in severe chronic constipation: a double blind study. [abstract]","volume":"32","author":"Benini","year":"1991","journal-title":"Gut"},{"issue":"8","key":"10.1002\/14651858.CD007780.pub2-BIB0011|cit11","first-page":"917","article-title":"Cisapride for the treatment of constipation in children.","volume":"37","author":"Bhatnagar","year":"2000","journal-title":"Indian Pediatr"},{"issue":"3","key":"10.1002\/14651858.CD007780.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005176-199604000-00007","article-title":"Cisapride therapy for gastrointestinal disease.[see comment]. [Review] [90 refs]","volume":"22","author":"Cucchiara","year":"1996","journal-title":"Journal of Pediatric Gastroenterology & Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD007780.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1046\/j.1365-2036.1997.00240.x","article-title":"Effects of oral cisapride on small bowel motility in irritable bowel syndrome","volume":"11","author":"Evans","year":"1997","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD007780.pub2-BIB0014|cit14","first-page":"285","article-title":"The effect of cisapride on segmental colonic transit time in patients with spinal cord injury.","volume":"90","author":"Geders","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1002\/14651858.CD007780.pub2-BIB0015|cit15","first-page":"121","article-title":"Double-blind dose-response study of cisapride in the treatment of chronic functional constipation","volume":"5","author":"Hernandez","year":"1988","journal-title":"ADV. THER."},{"issue":"21","key":"10.1002\/14651858.CD007780.pub2-BIB0016|cit16","first-page":"673","article-title":"The effect of cisapride on delayed colonic transit time in patients with idiopathic Parkinson's disease.","volume":"106","author":"Jost","year":"1994","journal-title":"Wien Klin Wochenschr"},{"issue":"8","key":"10.1002\/14651858.CD007780.pub2-BIB0017|cit17","first-page":"882","article-title":"Cisapride accelerates colonic transit in constipated patients with colonic inertia.","volume":"84","author":"Krevsky","year":"1989","journal-title":"Am J Gastroenterol."},{"issue":"1","key":"10.1002\/14651858.CD007780.pub2-BIB0018|cit18","first-page":"26","article-title":"Cisapride combined with bisacodyl and doxepin in treating functional constipation","volume":"21","author":"Liu","year":"2002","journal-title":"Chinese Journal of New Drugs and Clinical Remedies"},{"issue":"1","key":"10.1002\/14651858.CD007780.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00005176-199601000-00003","article-title":"Cisapride for children with intractable constipation: an interim verdict!","volume":"22","author":"Loening-Baucke","year":"1996","journal-title":"J Pediatr Gastroenterol Nutr."},{"issue":"5","key":"10.1002\/14651858.CD007780.pub2-BIB0020|cit20","first-page":"272","article-title":"Clinical efficacy of different drugs on irritable bowel syndrome","volume":"8","author":"Lu","year":"2003","journal-title":"Chinese Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD007780.pub2-BIB0021|cit21","first-page":"158","article-title":"Cisapride in chronic constipation and laxative abuse [abstract]","volume":"34","author":"M\u00fcller-Lissner","year":"1986","journal-title":"Digestion"},{"issue":"8","key":"10.1002\/14651858.CD007780.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/gut.28.8.1033","article-title":"Treatment of chronic constipation with cisapride and placebo.","volume":"28","author":"M\u00fcller-Lissner","year":"1987","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD007780.pub2-BIB0023|cit23","first-page":"69","article-title":"Cisapride in chronic idiopathic constipation: can the colon be re-educated? Bavarian Constipation Study Group.","volume":"7","author":"M\u00fcller-Lissner","year":"1995","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"6","key":"10.1002\/14651858.CD007780.pub2-BIB0024|cit24","first-page":"345","article-title":"Use of cisapride with magnesium oxide in chronic pediatric constipation.","volume":"42","author":"Ni","year":"2001","journal-title":"Acta Paediatr Taiwan."},{"issue":"1","key":"10.1002\/14651858.CD007780.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00005176-199601000-00006","article-title":"Treatment of intractable constipation in children: experience with cisapride","volume":"22","author":"Nurko","year":"1996","journal-title":"Journal of Pediatric Gastroenterology & Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD007780.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00005176-199708000-00012","article-title":"Use of cisapride in treatment of constipation in children.","volume":"25","author":"Odeka","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr."},{"issue":"5","key":"10.1002\/14651858.CD007780.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/ebm.5.5.150","article-title":"Cisapride was effective in the short term for constipation in children. Commentary","volume":"5","author":"Puntis","year":"2000","journal-title":"Evidence-Based Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007780.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2036.1997.133311000.x","article-title":"Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome.","volume":"11","author":"Sch\u00fctze","year":"1997","journal-title":"Aliment Pharmacol Ther."},{"issue":"5","key":"10.1002\/14651858.CD007780.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/BF02091525","article-title":"Cisapride in neurologically impaired children with chronic constipation.","volume":"41","author":"Staiano","year":"1996","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1002\/14651858.CD007780.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/gut.49.6.828","article-title":"Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial.","volume":"49","author":"Veysey","year":"2001","journal-title":"Gut"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0031|cit31","first-page":"268","article-title":"Anorectal manometric abnormalities and effect of cisapride on patients with chronic idiopathic constipation","volume":"18","author":"Zou","year":"1998","journal-title":"Chinese Journal of Digestion"},{"issue":"1","key":"10.1002\/14651858.CD007780.pub2-BIB0032|cit32","first-page":"197","article-title":"The Efficacy of Cisapride vs. Placebo and Diet in patients with Chronic Consitpation","volume":"27","author":"Altabas","year":"2003","journal-title":"Coll Antopol"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0033|cit33","unstructured":"Ambanatu H. J IS INDIA A DUMP YARD FOR HAZARDOUS DRUGS? : A COMPARATIVE STUDY OF REGULATION OF DRUGS IN INDIA AND OTHER COUNTRIES Commoncauseindia.org 2007"},{"issue":"4","key":"10.1002\/14651858.CD007780.pub2-BIB0034|cit34","article-title":"Cisapride treatment for gastro-oesophageal reflux in children","author":"Augood","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0035|cit35","first-page":"232","article-title":"Anoreactal functional testing: review of collective experience","volume":"97","author":"Azpiroz","year":"2002","journal-title":"Am. J. Gastroenterol"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0036|cit36","first-page":"194","article-title":"Rome I criteria are more sensitive than Rome II for the diagnosis of irritable bowel syndrome in Indian patients","volume":"24","author":"Banerjee","year":"2005","journal-title":"Asian Institute of Gastroenterology"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0037|cit37","unstructured":"Breckenridge A Suspension of Cisapride (Prepulsid) licences: Product withdrawal Committee on Safety of Medicines, London 2000"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/sj.bjp.0705762","article-title":"Review: Role of serotonin in the pathophysiology of the irritable bowel syndrome","volume":"141","author":"Crowell","year":"2004","journal-title":"British J. Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD007780.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00019053-200523050-00006","article-title":"The health-related quality of life and economic burden of constipation","volume":"23","author":"Dennison","year":"2005","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1002\/14651858.CD007780.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000212689","article-title":"A study of constipation in the elderly living at home","volume":"31","author":"Donald","year":"1985","journal-title":"Gerontology"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0041|cit41","unstructured":"Drossman D The Launch of Rome III RomeCriteria 2006"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0042|cit42","volume-title":"The Cambridge Illustrated History of Surgery","author":"Ellis","year":"2009"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0043|cit43","unstructured":"FDA Letter from FDA on Cisapride http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm173074.htm"},{"issue":"4","key":"10.1002\/14651858.CD007780.pub2-BIB0044|cit44","first-page":"269","article-title":"Review: Prokinetic agents: current aspects with focus on cisapride","volume":"13","author":"Georgiadis","year":"2000","journal-title":"Annals of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD007780.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2036.1999.00002.x-i2","article-title":"Roles played by 5-hydrocytrptamine in the physiology of the bowel","volume":"13","author":"Gershon","year":"1999","journal-title":"Ailment. Pharmacol"},{"issue":"2","key":"10.1002\/14651858.CD007780.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00005176-199902000-00020","article-title":"Cisapride in management of chronic pediatric constipation.","volume":"28","author":"Halabi","year":"1999","journal-title":"\u00a0J Pediatr Gastroenterol Nutr."},{"issue":"3","key":"10.1002\/14651858.CD007780.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2125.2008.03249.x","article-title":"Cisapride and ventricular arrhythmia","volume":"66","author":"Hennessy","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0048|cit48","first-page":"17","article-title":"Withdrawal of troglitazone and Cisapride","volume":"283","author":"Henney","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1572-0241.2004.04114.x","article-title":"Epidemiology of constipation in North America: a systematic review","volume":"99","author":"Higgins","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0050|cit50","first-page":"11","article-title":"A Review of Diabetic Gastropathy","volume":"27","author":"Lal","year":"2002","journal-title":"U.S. Pharmacist"},{"issue":"5","key":"10.1002\/14651858.CD007780.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bmj.2.6138.653","article-title":"Towards positive diagnosis of irritable bowel","volume":"2","author":"Manning","year":"1978","journal-title":"Br Med J"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000051888","article-title":"Paitents with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhoea-predominant patients and subjects with normal bowel habits","volume":"63","author":"Miwa","year":"2001","journal-title":"Digestion"},{"issue":"8","key":"10.1002\/14651858.CD007780.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/gut.28.8.1033","article-title":"Treatment of chronic constipation with cisapride and placebo.","volume":"28","author":"M\u00fcller-Lissner","year":"1987","journal-title":"Gut"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0055|cit55","unstructured":"National Collaborating Centre for Women\u2018sand Children\u2018s Health Constipation in children and young people:diagnosis and management of idiopathic childhood constipation inprimary and secondary care National Institute for Health and Clinical Excellence 2010 Clinical guidelines CG99"},{"issue":"2","key":"10.1002\/14651858.CD007780.pub2-BIB0056|cit56","first-page":"250","article-title":"Use of cisapride in treatment of idiopathic constipation in children.","volume":"25","author":"Odeka","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"10.1002\/14651858.CD007780.pub2-BIB0057|cit57","unstructured":"Website based Cisapride Internet"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0058|cit58","unstructured":"Website based Cisapride Internet"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-230X-8-5","article-title":"Epidemiology of constipation in Europe and Oceania: a systematic review","volume":"8","author":"Peppas","year":"2008","journal-title":"BMC Gastroenterology"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2036.1993.tb00088.x","article-title":"Cisapride in the treatment of gastroesophageal reflux disease","volume":"7","author":"Robertson","year":"1993","journal-title":"Alim Pharm Ther"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0061|cit61","unstructured":"Rome Foundation Rome III Criteria RomeCriteria.org 2006"},{"issue":"8","key":"10.1002\/14651858.CD007780.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/BF01296706","article-title":"Bowel habits in young adults not seeking health care","volume":"32","author":"Sandler","year":"1987","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1002\/14651858.CD007780.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/BF01536339","article-title":"Physician visits in the United States for constipation: 1958 to 1986","volume":"34","author":"Sonnenberg","year":"1989","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1002\/14651858.CD007780.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF01311229","article-title":"Effect of Cisapride on Chronic Idiopathic Consipation in Children","volume":"36","author":"Staiano","year":"1991","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2036.1992.tb00050.x","article-title":"Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications","volume":"6","author":"Tally","year":"1992","journal-title":"Aliment. Pharmacol"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1254\/jphs.SC0070243","article-title":"The 5-HT4 Agonists Cisapride, Mosapride, and CJ-033466, a Novel Potent Compound, Exhibit Different Human Ether-a-go-go-related Gene (hERG)-Blocking Activities","volume":"105","author":"Toga","year":"2007","journal-title":"Journal of Pharmacological Science"},{"issue":"7107","key":"10.1002\/14651858.CD007780.pub2-BIB0067|cit67","first-page":"152","article-title":"Cisapride withdrawn because of cardiac side effects","volume":"265","author":"TPJhttp:\/\/www.pharmj.com\/Editorial\/20000729\/clinical\/cisapride.htmlhttp:\/\/www.pharmj.com\/Editorial\/20000729\/clinical\/cisapride.html","year":"2000","journal-title":"The Pharmaceutical Journal"},{"key":"10.1002\/14651858.CD007780.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00005176-199905000-00017","article-title":"The role of Cisapride in the treatment of paediatric gastroesophageal reflux","volume":"28","author":"Vandenplas","year":"1999","journal-title":"J. Pediatr. Gastoenterol. Nutr"},{"issue":"6","key":"10.1002\/14651858.CD007780.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/gut.49.6.828","article-title":"Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial.","volume":"49","author":"Veysey","year":"2001","journal-title":"Gut"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007780.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T19:16:45Z","timestamp":1637090205000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007780.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Colorectal Cancer Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,1,19]]},"references-count":69,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007780.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,19]]}}}